Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer

References

Page 1

	Year	Citations
Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. Gary Cook, S. Houston, R.D. Rubens, Journal of Clinical Oncology	1998	563
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Paul Shreve, H. Barton Grossman, Milton D. Gross, Radiology	1996	396
Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer Thierry Bury, Ana Terra Fonseca Barreto, Frédéric Daenen, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyBone ImagingEngineeringOncologic ImagingMedical Imaging	1998	315
Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy Masateru Ohta, Yutaka Tokuda, Yasuhiro Suzuki, Nuclear Medicine Communications Positron Emission Tomography99Tcm-mdp Bone ScintigraphyBone ImagingHealth SciencesMedical Imaging	2001	177
Mechanisms of Lytic and Blastic Metastatic Disease of Bone C. S. B. Galasko Clinical Orthopaedics and Related Research Bone DiseaseBlastic Metastatic DiseaseOrthopaedic SurgeryProstaglandin InhibitorsBone Morphogenic Protein	1982	119
Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma. Hans Bender, J. Kirst, H. Palmedo, PubMed Positron Emission TomographyBreast OncologyEngineeringOncologic ImagingMedical Imaging	1997	119
Bone scanning M. V. Merrick British Journal of Radiology	1975	99
F-18 FDG Positron Emission Tomography and Benign Fractures Ivan Ho Shon, Ignac Fogelman Clinical Nuclear Medicine	2003	67
FDG-PET uptake in occult acute pelvic fracture James G. Ravenel, Leonie Gordon, Thomas Pope, Skeletal Radiology EngineeringMedical ImagingFracture DiagnosticsPet-mriPelvic Trauma	2004	25

Page 1